• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Goodman Property Trust

  • ID: 642014
  • March 2015
  • 34 Pages
  • Wright Investors Service

A textual analysis of the financial results for Goodman Property Trust compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Goodman Property Trust. There is a textual review of the financial results of Goodman Property Trust versus Precinct Properties New Zealand Limited, Kiwi Property Group Ltd and Argosy Property Limited. The comparative analysis of these companies compares Sales READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

New Zealand

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Goodman Fielder Ltd - Product Thumbnail Image

    Goodman Fielder Ltd

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Australand Property Group - Product Thumbnail Image

    Australand Property Group

    • Language: English
    • 37 Pages
    • Published: September 2014
  • Westfield Group - Product Thumbnail Image

    Westfield Group

    • Language: English
    • 38 Pages
    • Published: June 2014
  • Goodman Group - Product Thumbnail Image

    Goodman Group

    • Language: English
    • 34 Pages
    • Published: April 2015
    FROM
  • Kiwi Property Group Ltd - Product Thumbnail Image

    Kiwi Property Group Ltd

    • Language: English
    • 34 Pages
    • Published: March 2015
    FROM
  • Goodman Plus Trust - Product Thumbnail Image

    Goodman Plus Trust

    • Language: English
    • 33 Pages
    • Published: April 2015
    FROM
  • Argosy Property Limited - Product Thumbnail Image

    Argosy Property Limited

    • Language: English
    • 35 Pages
    • Published: April 2015
    FROM
  • Precinct Properties New Zealand Limited - Product Thumbnail Image

    Precinct Properties New Zealand Limited

    • Language: English
    • 34 Pages
    • Published: April 2015
    • Region: New Zealand
    FROM
  • Gowing Bros. Limited - Product Thumbnail Image

    Gowing Bros. Limited

    • Language: English
    • 34 Pages
    • Published: April 2015
    FROM
  • Dexus Property Group - Product Thumbnail Image

    Dexus Property Group

    • Language: English
    • 35 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.